Who invested in Sinopia Biosciences?
Sinopia Biosciences's investors include National Heart, Lung and Blood Institute and National Cancer Institute (NCI).

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$3.6Mraised across 3 rounds since 2025, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $2.8M sold, first sale Jul 2026
Source recorded
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Sinopia Biosciences's investors include National Heart, Lung and Blood Institute and National Cancer Institute (NCI).
Sinopia Biosciences has raised $3.6M across 3 rounds since 2025.
Sinopia Biosciences's most recent round, $2.8M, was in Jul 2026.
Its most recent round, $2.8M in Jul 2026, is also its largest on record.
Sinopia Biosciences's first round on record, in Dec 2025, was backed by National Heart, Lung and Blood Institute.
Sinopia Biosciences's latest named round is a Grant, in Mar 2026.
Sinopia Biosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.